Trial Profile
Phase 1 dose-escalation trial of AQX 1125 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Apr 2013
Price :
$35
*
At a glance
- Drugs Rosiptor (Primary)
- Indications Allergic asthma; Chronic obstructive pulmonary disease
- Focus Adverse reactions; Pharmacokinetics
- 05 Apr 2013 New trial record